Angela Rizzo1, Sara Iachettini2, Pasquale Zizza3, Chiara Cingolani4, Manuela Porru5, Simona Artuso6, Malcolm Stevens7, Marc Hummersone8, Annamaria Biroccio9, Erica Salvati10, Carlo Leonetti11. 1. Experimental Chemotherapy Laboratory, Regina Elena National Cancer Institute, Nottingham, NG7 2RD, UK. angela.rizzo@ifo.it. 2. Experimental Chemotherapy Laboratory, Regina Elena National Cancer Institute, Nottingham, NG7 2RD, UK. sara.iachettini@gmail.com. 3. Experimental Chemotherapy Laboratory, Regina Elena National Cancer Institute, Nottingham, NG7 2RD, UK. zizza@ifo.it. 4. Experimental Chemotherapy Laboratory, Regina Elena National Cancer Institute, Nottingham, NG7 2RD, UK. chiara.cingolani@hotmail.com. 5. Experimental Chemotherapy Laboratory, Regina Elena National Cancer Institute, Nottingham, NG7 2RD, UK. manuelaporru@tiscali.it. 6. Experimental Chemotherapy Laboratory, Regina Elena National Cancer Institute, Nottingham, NG7 2RD, UK. artusem@inwind.it. 7. School of Pharmacy, University of Nottingham, Nottingham, NG7 2RD, UK. Malcolm.Stevens@nottingham.ac.uk. 8. Pharminox Ltd, Biocity, Pennyfoot St, Nottingham, NG1 1GF, UK. marc.hummersone@pharminox.com. 9. Experimental Chemotherapy Laboratory, Regina Elena National Cancer Institute, Nottingham, NG7 2RD, UK. biroccio@ifo.it. 10. Experimental Chemotherapy Laboratory, Regina Elena National Cancer Institute, Nottingham, NG7 2RD, UK. erica.salvati@gmail.com. 11. Experimental Chemotherapy Laboratory, Regina Elena National Cancer Institute, Nottingham, NG7 2RD, UK. leonetti@ifo.it.
After the publication of this article [1] the authors noticed an error in the Acknowledgements section. The corrected Acknowledgments is included below. The authors apologise for any inconvenience.